(Date:7/9/2008)...ans Health Care, WASHINGTON, July 9 /PRNewswire-U...f Government Employees (AFGE) launched a nationwid... Senator McCain,s commitment to,veterans, health c...resents,employees in the Department of Veterans Af...com, and a series of YouTube ads featuring union ...
(Date:7/9/2008)...promazine Maleate (Acepromazine) is on extended ba...will compound this preparation into Gourmeds™...vored suspension in the most frequently prescribed...cription for veterinary use only. , ...uly 9, 2008 -- Commonly prescribed for both cats ...
(Date:7/9/2008)...enses to Protect Eyes This Summer and ...Fla., July 9 /PRNewswire/ -- While consumers are a...ts effects on the skin, many,are not aware that th...by,the New England Eye Institute and Transitions O...eport knowing that UV exposure can cause skin canc...
(Date:7/9/2008)...USNewswire/ -- Updates on the impact of,climate ch...A infections,and the importance of childhood immu...e at the National Press Club in Washington, D.C. T...dation for Infectious Diseases,(NFID), also addres...ent of,infections due to drug resistant bacteria.,...
Breaking Medicine News(10 mins):Health News:Union Representing VA Workers Launch Nationwide Radio Campaign, Web Site and Viral Videos for Full VA Funding 2Health News: Wedgewood Pharmacy Responds to Acepromazine Maleate Drug Shortage 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 3Health News:Public Health Experts Provide Update on Current Infectious Diseases Threats 2Health News:Public Health Experts Provide Update on Current Infectious Diseases Threats 3Detect masses in the breast
... injury to most or all of both lungs. Patients wit...re on life support. //A new study finds the age of...fter a trauma. ARDS is not a specific disease; ins... associated with a number of diseases including pn...
...of viral particles isolated from humans with SARS ...ed //and being held in a retail food market. The a...99.8 percent genetically identical to a virus that...y syndrome, or SARS, in humans. Their findings sug...
...rmone could suppress the appetites of lean people.... obese people because studies of another appetite-...nting. "We had to do a second trial to see if obes...ne, said researchers. The answer: "Yes, they are. ...
Other Medicine News:Health News:SARS research confirms link to animals 2Health News:Extra hormone found to cut appetite by a third 2(Date:7/7/2008)...swire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulleti...biopharmaceutical,company specializing in the prev... provided an operational update on the company,s p...n clinical trial testing and,plans to proceed into...ive,successful human trials evaluating GeoVax AIDS...
(Date:7/7/2008)...s Kiwifruit is Top Performer in the Body, SEATTLE...d equal when,it comes to their antioxidant powers ...availability compared to other antioxidant-rich fr...lished in the Journal of the,American College of N...ochemicals called flavonoids that,may have the pow...
(Date:7/3/2008)... /PRNewswire-USNewswire/ -- All newborn infants,sh...is present at birth,according to a new recommenda... The recommendation and the accompanying summary o...s., Children whose hearing is impaired at birth, ...lems with verbal and nonverbal communication and,s...
(Date:7/2/2008)...ficacy Endpoint Met in Stage 1 of Two-Stage Study ...valuable Patients to Date Continue to Show Objecti...isease -, TUSTIN, Calif., July 2 /PRNewswire-Firs... PPHM ) today reported that its lead product,cand... 1 primary endpoint,in its ongoing Phase II clinic...
Breaking Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 1iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 2iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 3Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 1Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 2Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 3QED International Associates Announces Changes to the HealthShares 28TM 29 Cardio Devices Index 28As Revised 29 16018 1Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 1Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 2Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 3... Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- Ne...ogical and,pharmacokinetic profiles of Basilea,s (...ole and isavuconazole. Studies reported,both for c...phalosporin in late-stage development, and for isa...asive fungal infections,yielded further data on t...
...France, April 04, 2007 /PRNewswire/ -- Novagali Ph...y specialized in,ophthalmology, announces today po...f Vekacia(R) in children suffering from Vernal,Ker...t was shown,that both symptoms and signs of diseas...ermore, the tolerability to Vekacia(R),was excelle...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reus
The MicroTouch LP (low profile) is specifically designed for use on cystoscopy tables with a fixed fluoroscopy/x-ray gantry. The MicroTouch LP attaches to tables on the side opposite the gantry and a
The Precision Stepper is the first stepper with a fully adjustable baseline. This new technology permits the physician to fine-tune the depth of the ultrasound transducer for accurate imaging and pr
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy.
Medicine Products: